Ageing

Global Toxoid Vaccine Market Report 2022 to 2028: Featuring Astellas Pharma, Bharat Biotech, Novartis and Pfizer Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, December 5, 2022
Health, Pharmaceutical, TD, Ageing, Diphtheria, Whooping cough, UIP, Prevalence, Hospital, Death, Disease, National Health Mission, TT, DT, World Health Organization, Government, ClinicalTrials.gov, Tetanus, Vaccine, Growth, Immunity, WHO, TDAP, DPT vaccine, Marketing

The global toxoid vaccine market is segmented based on disease, composition, form, and end-user.

Key Points: 
  • The global toxoid vaccine market is segmented based on disease, composition, form, and end-user.
  • Geographically, the global toxoid vaccine market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
  • The North American region is expected to hold a prominent market share in the global toxoid vaccine market.
  • Insights about market determinants that are stimulating the global toxoid vaccine market.

Worldwide Healthcare Industry Report to 2026 - Featuring Eurostat, IMF, United Nations and World Health Organization Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, December 5, 2022
Health, General Health, Affect, GDP, World Bank, OECD, Central Intelligence Agency, Parity, International Monetary Fund, Ageing, Health care, Uruguay and the International Monetary Fund, Gross domestic product, Pet, Healthcare, Eurostat

This report forecasts to 2022 and 2026 the following measures related to global healthcare: healthcare expenditures, healthcare expenditures per capita, healthcare expenditures as a share of GDP, population, and population 50 years of age and older.

Key Points: 
  • This report forecasts to 2022 and 2026 the following measures related to global healthcare: healthcare expenditures, healthcare expenditures per capita, healthcare expenditures as a share of GDP, population, and population 50 years of age and older.
  • Healthcare expenditures are measured in real (inflation-adjusted) US dollars.
  • World regions include North America, Western Europe, Asia/Pacific, and all other regions.
  • In addition, for the three main regions, total and per capita healthcare expenditures are forecast for the largest economies within that region.

BrainTale Has Presented the Interest If Its Digital Biomarkers Platform in Differential Diagnosis During the 15th Edition of Clinical Trials on Alzheimer’s Disease Conference

Retrieved on: 
Monday, December 5, 2022
Medical Devices, Health, Neurology, Other Health, Clinical Trials, Biotechnology, Hospital, Neurological disorder, Degenerative disease, Physician, Neurodegeneration, Clinical trial, Disease, Amyotrophic lateral sclerosis, Diagnosis, Diffusion, Dementia, Biomarker, Patient, ISO, Research, CSO, White matter, HIV disease progression rates, Neurology, Incidence, MDR, European Medical Writers Association, Axon, Ageing, Adaptive clinical trial, Brain, Myelin, Risk, Medical imaging, Pharmaceutical industry, Medical device, Alzheimer's disease

Alzheimers disease affects about 10 million people per year worldwide and its incidence rate tends to increase year after year.

Key Points: 
  • Alzheimers disease affects about 10 million people per year worldwide and its incidence rate tends to increase year after year.
  • Results show that BrainTale biomarkers are relevant biomarkers of disease severity, and that the platform has the potential for a differentiated diagnosis perspective.
  • Our data suggest a very exciting complementary approach to existing initiatives to better diagnose, and ultimately better treat Alzheimers disease patients.
  • With non-invasive, sensitive and reliable measurements of white matter microstructure alterations, BrainTale offers a digital biomarkers platform to support clinical decision-making.

Capstone Green Energy Continues Its Success in the EaaS Market With a New C800S Rental Contract for a Data Mining Operation in West Texas

Retrieved on: 
Monday, December 5, 2022
Professional Services, Environment, Cryptocurrency, Alternative Energy, Green Technology, Energy, Hydrogen, EGT, Electricity, Security (finance), Computer, ESS, Intellectual property, Sustainable products, FPP, Weather, Ball State Center for Energy Research/Education/Service, Lone Star, Data mining, Capstone Green Energy, Energy, COVID-19, Cloud computing, Growth, Ageing, Risk, Carbon, Renewable energy, Capstone

Capstone Green Energy Corporation (NASDAQ: CGRN), a global leader in carbon reduction and on-site resilient green energy solutions, continues to grow in the Energy as a Service (EaaS) market with a new 2-year rental agreement for a cryptocurrency data mining operation in West Texas.

Key Points: 
  • Capstone Green Energy Corporation (NASDAQ: CGRN), a global leader in carbon reduction and on-site resilient green energy solutions, continues to grow in the Energy as a Service (EaaS) market with a new 2-year rental agreement for a cryptocurrency data mining operation in West Texas.
  • Cryptocurrency mining requires highly sophisticated computers, often in a data center, to solve complex computational mathematical problems.
  • Additionally, using otherwise wasted (flared) gases for bitcoin production minimizes the environmental impact of data mining activities, said Marc Rouse, Sales Director, Capstone Green Energy.
  • Through Hydrogen & Sustainable Products (H2S), Capstone Green Energy offers customers a variety of hydrogen products, including the Company's microturbine energy systems.

Tenchijin Wins First Prize at Copernicus Masters, Japan Regional Prize 2022: A Water Leakage Risk Map for Local Governments and Private Water Utilities

Retrieved on: 
Monday, December 5, 2022
Aerospace, Data Management, Energy, Satellite, Manufacturing, Start-Up, Technology, Professional Services, Other Natural Resources, Natural Resources, Science, Software, Other Science, Data Analytics, Research, Utilities, Water, Union, Toyota, Weather, Tenchijin, COMPASS, Nicolaus Copernicus, Soil, Deep learning, ESA, Data analysis, Ageing, European Space Agency, Local government, Algorithm, Surveying, EU

Tenchijin developed a leakage risk map by utilizing deep learning algorithms to analyze original leakage data in their product COMPASS.

Key Points: 
  • Tenchijin developed a leakage risk map by utilizing deep learning algorithms to analyze original leakage data in their product COMPASS.
  • In Japan, 8% of the nations annual domestic water supply is lost by leakage due to aging water pipelines, and 18% of the total water pipelines in Japan have exceeded their statutory durability age.
  • However, the local government has a limited budget to repair the existing water pipelines, the cost of which is becoming prohibitive.
  • In order to visualize and evaluate the issue, Tenchijin developed a leakage risk map that can identify areas at high risk of leakage.

BioAge Announces Positive Topline Results for BGE-105 in Phase 1b Clinical Trial Evaluating Muscle Atrophy in Older Volunteers at Bed Rest

Retrieved on: 
Monday, December 5, 2022
Research, FDA, Genetics, Clinical Trials, Biotechnology, Managed Care, Health, Pharmaceutical, Science, Muscle, Phase II, Therapy, Muscle atrophy, Duke University, APJ, Ageing, Apelin, Exercise, Kirin-Amgen Inc v Hoechst Marion Roussel Ltd, Doctor of Philosophy, University of California, Berkeley, Steatosis, ICU, Patient, Amgen, Immobilization, Degenerative disease, Longevity, NLRP3, Disease, Kaiser Permanente, Woman, Quality of life, Khosla Ventures, Growth, Interest, Safety, Hospital, Mortality, Volunteering, Myopathy, Bed rest, Risk, Pharmaceutical industry, Dietary supplement, Medical imaging

BGE-105 treatment resulted in statistically significant prevention of muscle atrophy relative to placebo in healthy volunteers aged 65 or older after 10 days of strict bed rest.

Key Points: 
  • BGE-105 treatment resulted in statistically significant prevention of muscle atrophy relative to placebo in healthy volunteers aged 65 or older after 10 days of strict bed rest.
  • Twenty-one volunteers underwent 10 days of bed rest while receiving infusions of BGE-105 or placebo.
  • Muscle protein synthesis: Proteomic analysis of muscle microbiopsy samples revealed that bed rest decreased production of muscle proteins, and this effect was significantly ameliorated by BGE-105 (p
  • BioAge has multiple programs targeting muscle, immune, and brain aging, including the clinical-stage apelin receptor agonist BGE-105 and a differentiated CNS-penetrant NLRP3 inhibitor.

Bardstown Bourbon Co. Announces The Origin Series

Retrieved on: 
Monday, December 5, 2022
Online Retail, Retail, Consumer, Wine & Spirits, Men, Food, Beverage, Trail's End Kentucky Straight Bourbon Whiskey, Ageing, Rugby League War of the Roses, Collection, Nose, Vanilla, Palate, State of Origin, Multimedia, Taste, New product development, Beer

View the full release here: https://www.businesswire.com/news/home/20221205005129/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221205005129/en/
    Bardstown Bourbon Co. will release three core products in 2023 - Origin Series Kentucky Straight Bourbon, Origin Series Bottled-in-Bond wheated and Origin Series Rye - all of which were distilled, aged and bottled at the brand's Bardstown, Ky.
  • (Photo: Business Wire)
    The Origin Series introduces consumers to the modern brands core product line through three distinct 6-year-old whiskies: Origin Kentucky Straight Bourbon Whiskey, Origin Bottled-in-Bond and Origin Kentucky Straight Rye Whiskey.
  • Origin Series Bourbon is a 6-year-old Kentucky Straight Bourbon Whiskey.
  • In addition to the three core products, the launch of the Origin Series will include for the first time, a single barrel program for Bardstown Bourbon Co. A limited number of Origin Series Bourbon single barrels will be available annually for purchase by the barrel to on- and off-premise retailers.

Value-oriented social media platform TouchApp removes thousands of harmful social media posts

Retrieved on: 
Monday, December 5, 2022
Software, Mobile, Wireless, Internet, Data Management, Consumer, Mental Health, Apps, Applications, Technology, Teens, Children, Other Consumer, Health, Telecommunications, Social media, Ageing, Racism, Internet, Bullying, Research, Ofcom, Knowledge, Parent, Social anxiety, Mental health, Islam, Multimedia, Marketing

Studies found that 21% of young people had increased social anxiety after spending time on social media, with half expressing body dissatisfaction.

Key Points: 
  • Studies found that 21% of young people had increased social anxiety after spending time on social media, with half expressing body dissatisfaction.
  • Another study showed that those aged 16-21 who use social media for 7 hours or more a day had decreased levels of life satisfaction.
  • View the full release here: https://www.businesswire.com/news/home/20221205005060/en/
    Value-oriented social media platform TouchApp removes thousands of harmful social media posts (Photo: Business Wire)
    TouchApp Founder and CEO Islam Faisal explained, Social media platforms promote fake lifestyles.
  • Most children under 13 have an account on at least one social media platform.

Leeaf Named Among 2022's Top "20 Most innovative Companies to Watch" by Business Worldwide Magazine

Retrieved on: 
Wednesday, December 7, 2022
Mecum Dealmakers, Physician, Ageing, Female, UCLA Health, IVF, Biomarker, Patient, Medtech, Personal injury lawyer, Intelligence, AI, Woman, News, Infertility, Fertility, Legislation, Algorithm, Birth control, Medical device

LONDON, Dec. 7, 2022 /PRNewswire/ -- Prague based medtech company Leeaf has been recognized by Business Worldwide Magazine in its "20 Most Innovative Companies to Watch, 2022" awards.

Key Points: 
  • LONDON, Dec. 7, 2022 /PRNewswire/ -- Prague based medtech company Leeaf has been recognized by Business Worldwide Magazine in its "20 Most Innovative Companies to Watch, 2022" awards.
  • Whether it's healthcare, banking, industry, construction, energy or more, these companies are at the cutting edge of breakthrough technologies, innovation, and modernized business structures.
  • Those included have a shared goal of developing revolutionary products and technology that can drive scalable business models and disrupt established industries and markets.
  • To see the full top 20 list and find out more about the full range of Business Worldwide Magazine Awards, https://www.bwmonline.com/awards/20-most-innovative-companies-to-watch-a...
    Business Worldwide Magazine is the leading source of business and dealmaker intelligence throughout the world.

Leeaf Named Among 2022's Top "20 Most innovative Companies to Watch" by Business Worldwide Magazine

Retrieved on: 
Wednesday, December 7, 2022
Mecum Dealmakers, Physician, Ageing, Female, UCLA Health, IVF, Biomarker, Patient, Medtech, Personal injury lawyer, Intelligence, AI, Woman, News, Infertility, Fertility, Legislation, Algorithm, Birth control, Medical device

LONDON, Dec. 7, 2022 /PRNewswire/ -- Prague based medtech company Leeaf has been recognized by Business Worldwide Magazine in its "20 Most Innovative Companies to Watch, 2022" awards.

Key Points: 
  • LONDON, Dec. 7, 2022 /PRNewswire/ -- Prague based medtech company Leeaf has been recognized by Business Worldwide Magazine in its "20 Most Innovative Companies to Watch, 2022" awards.
  • Whether it's healthcare, banking, industry, construction, energy or more, these companies are at the cutting edge of breakthrough technologies, innovation, and modernized business structures.
  • Those included have a shared goal of developing revolutionary products and technology that can drive scalable business models and disrupt established industries and markets.
  • To see the full top 20 list and find out more about the full range of Business Worldwide Magazine Awards, https://www.bwmonline.com/awards/20-most-innovative-companies-to-watch-a...
    Business Worldwide Magazine is the leading source of business and dealmaker intelligence throughout the world.